omniture
logo
Search
Hanmi Pharmaceutical Co.Ltd.
Media Room

Latest News

rss

Hanmi's Oral Delivery Platform Compound Licensed to Gilead

Hanmi and HHP will grant Gilead an exclusive license to Encequidar and provide access to drug suppl...

2025-09-29 17:45 957

Hanmi Pharmaceutical's 'Gugutams' to be Launched in Mexico as 'Aditams', Marking the Start of Full-Scale Latin America Expansion

Hanmi Pharm Begins Local Sales of Urological Product 'Aditams' in Mexico with Partner 'Laboratorios...

2025-04-02 12:17 2377
Hanmi Pharmaceutical's 'Gugutams' to be Launched in Mexico as 'Aditams', Marking the Start of Full-Scale Latin America Expansion

Beyond Pouch Packaging: Hanmi Pharmaceutical Introduces a New Automated Vial Dispensing Solution in Canada and the United States

* Hanmi Pharmaceutical Global Business Headquarters Accelerates Expansion into Canadian and US Ma...

2025-02-14 08:35 2323
Beyond Pouch Packaging: Hanmi Pharmaceutical Introduces a New Automated Vial Dispensing Solution in Canada and the United States

Hanmi Pharmaceutical and Beijing Hanmi Progress Clinical Trials of Co-developed BH3120 as a Next-Generation Cancer Immunotherapy

Hanmi unveils tiral in progress poster on BH3120 at the Society for Immunotherapy of Cancer (SITC) ...

2024-11-25 09:30 2079

Hanmi Unveils Novel Obesity Drug 'HM17321' : A Game-Changer in Overcoming GLP-1-Associated Muscle Loss

Fat Loss Augmentation + Lean Mass Increase Hanmi Presents Three Breakthrough Findings on Novel Obes...

2024-11-06 15:41 1706

Hanmi Enters into Clinical Trial Collaboration and Supply Agreement with MSD to Evaluate BH3120 in Combination with KEYTRUDA® (pembrolizumab)

Hanmi Pharmaceutical announces Clinical Trial Collaboration with MSD to evaluate 'BH3120' in combin...

2024-04-24 09:27 2032

Hanmi Pharmaceutical's Combination Drug for Dyslipidemia Treatment, 'Rosuzet': Confirmed Non-inferiority Efficacy and Safety Compared to Monotherapy in 'The Lancet' & 'European Heart Journal'

SEOUL, South Korea, March 17, 2023 /PRNewswire/ -- Hanmi Pharmaceuticals (128940.KS), a subsidiary ...

2023-03-17 21:00 4190

Hanmi Fine Chemical Launches 'high-tech CDMO' Business

CDMO business initiated such as mRNA vaccine raw materials·peptides 10 billion KRW invested in Hanm...

2022-05-23 08:32 2715
Hanmi Fine Chemical Launches 'high-tech CDMO' Business

Hanmi Pharmaceutical finds new innovative potential for "Efpeglenatide"

SEOUL, South Korea, June 29, 2021 /PRNewswire/ -- Hanmi Pharmaceutical (hereinafter Hanmi) recently...

2021-06-29 21:00 2657
Hanmi Pharmaceutical finds new innovative potential for

Hanmi Pharmaceutical expects U.S. FDA approval for 2 new drugs

* Rolontis and Oraxol BLA/NDA approval from U.S. FDA is expected within this year * LAPSTriple ...

2021-01-18 22:00 3124
Hanmi Pharmaceutical expects U.S. FDA approval for 2 new drugs

Hanmi presents solution package for coping with COVID-19, including the mass production of nucleic acid vaccines (DNA/mRNA vaccine)

SEOUL, South Korea, Jan. 13, 2021 /PRNewswire/ -- Hanmi Pharmaceutical Co., Ltd., announced "endle...

2021-01-13 09:00 3033
Hanmi presents solution package for coping with COVID-19, including the mass production of nucleic acid vaccines (DNA/mRNA vaccine)